Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.45 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | ESRRG | P62508 | 5/20 | 0.44 |
| ▸ | SLC13A5 | Q86YT5 | 2/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
| ▸ | ESRRB | O95718 | 2/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL66122 | 1.00 | TP53 (0.52) | TP53TSHRKCNH2GPR84GRIA4 | |
| Methane SCHEMBL9798334 | 0.98 | TP53 (0.50) | TP53TSHRKCNH2GPR84GRIA4 | |
| SCHEMBL1068676 | 0.88 | KCNH2 (0.53) | TP53TSHRKCNH2GPR84GRIA4 | |
| SCHEMBL30522104 | 0.87 | TP53 (0.45) | TP53TSHRKCNH2GPR84GRIA4 | |
| SCHEMBL5091992 | 0.85 | TP53 (0.79) | TP53TSHRKCNH2GPR84GRIA4 | |
| SCHEMBL13991700 | 0.82 | NPC1 (0.40) | TP53TSHRKCNH2GPR84LMNA | |
| SCHEMBL9671868 | 0.82 | HIF1A (0.37) | CA2LMNA | |
| SCHEMBL21176934 | 0.81 | ESR1 (0.39) | TP53TSHRKCNH2GPR84ESRRG | |
| SCHEMBL30536048 | 0.81 | RORC (0.38) | TP53TSHRKCNH2GPR84GRIA4 | |
| SCHEMBL3639494 | 0.80 | TSHR (0.57) | TP53TSHRKCNH2GPR84GRIA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3596192-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | The Procter and Gamble Company (US) | 2020-01-22 | — | — | EP | disclosed |
| EP-3541435-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | Firmenich SA (CH) | 2019-09-25 | — | — | EP | disclosed |
| WO-2018169531-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2018091686-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH SA (CH) | 2018-05-24 | — | — | WO | disclosed |
| EP-3145837-A1 | FRESHENING PRODUCT COMPRISING AN AQUEOUS PERFUME COMPOSITION CONTAINED IN A PRESSURIZED PLASTIC CONTAINER | The Procter & Gamble Company (US) | 2017-03-29 | — | — | EP | disclosed |
| EP-3052605-A1 | COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED POLYAMINE POLYMER COMPATIBLE PERFUME MATERIALS | The Procter & Gamble Company (US) | 2016-08-10 | — | — | EP | disclosed |
| EP-3052147-A1 | COMPOSITIONS COMPRISING POLYAMINE POLYMER COMPATIBLE PERFUME MATERIALS | The Procter & Gamble Company (US) | 2016-08-10 | — | — | EP | disclosed |
| EP-2861702-A2 | MALODOR CONTROL COMPOSITIONS HAVING ACTIVATED ALKENES AND METHODS THEREOF | The Procter & Gamble Company (US) | 2015-04-22 | — | — | EP | disclosed |
| WO-2015050915-A1 | COMPOSITIONS COMPRISING POLYAMINE POLYMER COMPATIBLE PERFUME MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2015-04-09 | — | — | WO | disclosed |
| WO-2015050916-A1 | COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED POLYAMINE POLYMER COMPATIBLE PERFUME MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2015-04-09 | — | — | WO | disclosed |
| WO-2013188757-A2 | MALODOR CONTROL COMPOSITIONS HAVING ACTIVATED ALKENES AND METHODS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-19 | — | — | WO | disclosed |
| EP-2648770-A2 | UNSCENTED AND LOW SCENTED MALODOR CONTROL COMPOSITIONS AND METHODS THEREOF | The Procter and Gamble Company (US) | 2013-10-16 | — | — | EP | disclosed |
| EP-2513280-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2496681-A1 | HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT | The Procter & Gamble Company (US) | 2012-09-12 | — | — | EP | disclosed |
| WO-2012078626-A2 | UNSCENTED AND LOW SCENTED MALODOR CONTROL COMPOSITIONS AND METHODS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-14 | — | — | WO | disclosed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011056934-A1 | HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |